⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3835480 | 0.89 | EPHX1 (0.31) | — | |
| SCHEMBL10881341 | 0.87 | EPHX1 (0.39) | — | |
| SCHEMBL4652980 | 0.83 | EPHX1 (0.35) | — | |
| SCHEMBL5460780 | 0.81 | EPHX1 (0.39) | — | |
| SCHEMBL1936361 | 0.81 | EPHX1 (0.39) | — | |
| SCHEMBL11503387 | 0.81 | EPHX1 (0.39) | — | |
| SCHEMBL1193149 | 0.71 | — | — | |
| SCHEMBL349125 | 0.71 | — | — | |
| SCHEMBL15911064 | 0.69 | PLG (0.35) | — | |
| SCHEMBL21430439 | 0.69 | PLG (0.37) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1986598-A1 | UV FILTER CAPSULES COMPRISING AN AMINOSUBSTITUTED HYDROXYBENZOPHENONE | Merck Patent GmbH (DE) | 2008-11-05 | — | — | EP | disclosed |
| WO-2007093252-A1 | UV FILTER CAPSULES COMPRISING AN AMINOSUBSTITUTED HYDROXYBENZOPHENONE | MERCK PATENT GMBH (DE) | 2007-08-23 | — | — | WO | disclosed |
| EP-1549669-A1 | TUMOR TARGETING AGENTS AND USES THEREOF | Karyon OY (FI) | 2005-07-06 | — | — | EP | disclosed |
| WO-2004031221-A9 | TUMOR TARGETING AGENTS AND USES THEREOF | KARYON OY (FI) | 2004-07-08 | — | — | WO | disclosed |
| WO-2004031221-A1 | TUMOR TARGETING AGENTS AND USES THEREOF | KARYON OY (FI) | 2004-04-15 | — | — | WO | disclosed |
| EP-1114061-A1 | FACTOR VIIa INHIBITORS | Aventis Pharma Deutschland GmbH (DE) | 2001-07-11 | — | — | EP | disclosed |
| WO-2000015658-A1 | FACTOR VIIa INHIBITORS | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2000-03-23 | — | — | WO | disclosed |
| US-5811422-A | USEFUL FOR TREATING VIRAL INFECTIONS | THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) | 1998-09-22 | — | — | US | disclosed |
| US-5610294-A | VIRAL TREATMENT | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1997-03-11 | — | — | US | disclosed |
| EP-0323487-B1 | HETEROCYCLIC COMPOUNDS | CIBA-GEIGY AG (CH) | 1993-03-31 | — | — | EP | disclosed |
| EP-0323487-A1 | HETEROCYCLIC COMPOUNDS. | HOFFMANN LA ROCHE (CH) | 1989-07-12 | — | — | EP | disclosed |
| WO-1988010254-A1 | HETEROCYCLIC COMPOUNDS | F. HOFFMANN-LA ROCHE & CO. AKTIENGESELLSCHAFT (CH) | 1988-12-29 | — | — | WO | disclosed |